377 related articles for article (PubMed ID: 25531567)
1. Serum amyloid A and inflammation in diabetic kidney disease and podocytes.
Anderberg RJ; Meek RL; Hudkins KL; Cooney SK; Alpers CE; Leboeuf RC; Tuttle KR
Lab Invest; 2015 Mar; 95(3):250-62. PubMed ID: 25531567
[TBL] [Abstract][Full Text] [Related]
2. Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease.
Dieter BP; Meek RL; Anderberg RJ; Cooney SK; Bergin JL; Zhang H; Nair V; Kretzler M; Brosius FC; Tuttle KR
PLoS One; 2019; 14(2):e0211555. PubMed ID: 30763329
[TBL] [Abstract][Full Text] [Related]
3. Glomerular cell death and inflammation with high-protein diet and diabetes.
Meek RL; LeBoeuf RC; Saha SA; Alpers CE; Hudkins KL; Cooney SK; Anderberg RJ; Tuttle KR
Nephrol Dial Transplant; 2013 Jul; 28(7):1711-20. PubMed ID: 23314315
[TBL] [Abstract][Full Text] [Related]
4. Crocin Protects Podocytes Against Oxidative Stress and Inflammation Induced by High Glucose Through Inhibition of NF-κB.
Li S; Liu X; Lei J; Yang J; Tian P; Gao Y
Cell Physiol Biochem; 2017; 42(4):1481-1492. PubMed ID: 28719912
[TBL] [Abstract][Full Text] [Related]
5. FTO-mediated m6A modification of serum amyloid A2 mRNA promotes podocyte injury and inflammation by activating the NF-κB signaling pathway.
Lang Y; Wang Q; Sheng Q; Lu S; Yang M; Kong Z; Gao Y; Fan X; Shen N; Wang R; Lv Z
FASEB J; 2024 Jan; 38(2):e23409. PubMed ID: 38193628
[TBL] [Abstract][Full Text] [Related]
6. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
7. Protective Effect of Irbesartan by Inhibiting ANGPTL2 Expression in Diabetic Kidney Disease.
Fang LN; Zhong S; Huang LJ; Lu B; Shen LW; Tang FY; Sun HP; Zhang L
Curr Med Sci; 2020 Dec; 40(6):1114-1120. PubMed ID: 33263178
[TBL] [Abstract][Full Text] [Related]
8. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease.
Majumder S; Hadden MJ; Thieme K; Batchu SN; Niveditha D; Chowdhury S; Yerra VG; Advani SL; Bowskill BB; Liu Y; Vakili H; Alghamdi TA; White KE; Geldenhuys L; Siddiqi FS; Advani A
Diabetologia; 2019 Nov; 62(11):2129-2142. PubMed ID: 31399844
[TBL] [Abstract][Full Text] [Related]
10. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
11. Hirudin Protects Against Kidney Damage in Streptozotocin-Induced Diabetic Nephropathy Rats by Inhibiting Inflammation via P38 MAPK/NF-κB Pathway.
Han J; Pang X; Zhang Y; Peng Z; Shi X; Xing Y
Drug Des Devel Ther; 2020; 14():3223-3234. PubMed ID: 32848363
[TBL] [Abstract][Full Text] [Related]
12. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
Saulnier PJ; Dieter BP; Tanamas SK; McPherson SM; Wheelock KM; Knowler WC; Looker HC; Meek RL; Nelson RG; Tuttle KR
Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
[TBL] [Abstract][Full Text] [Related]
13. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
14. PTPN14 deficiency alleviates podocyte injury through suppressing inflammation and fibrosis by targeting TRIP6 in diabetic nephropathy.
Lin Y; Shao Z; Zhao M; Li J; Xu X
Biochem Biophys Res Commun; 2021 Apr; 550():62-69. PubMed ID: 33684622
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
[TBL] [Abstract][Full Text] [Related]
16. Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
Falkevall A; Mehlem A; Palombo I; Heller Sahlgren B; Ebarasi L; He L; Ytterberg AJ; Olauson H; Axelsson J; Sundelin B; Patrakka J; Scotney P; Nash A; Eriksson U
Cell Metab; 2017 Mar; 25(3):713-726. PubMed ID: 28190774
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin protects podocytes in diabetic kidney disease.
Merscher-Gomez S; Guzman J; Pedigo CE; Lehto M; Aguillon-Prada R; Mendez A; Lassenius MI; Forsblom C; Yoo T; Villarreal R; Maiguel D; Johnson K; Goldberg R; Nair V; Randolph A; Kretzler M; Nelson RG; Burke GW; Groop PH; Fornoni A;
Diabetes; 2013 Nov; 62(11):3817-27. PubMed ID: 23835338
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease.
Dieter BP; McPherson SM; Afkarian M; de Boer IH; Mehrotra R; Short R; Barbosa-Leiker C; Alicic RZ; Meek RL; Tuttle KR
J Diabetes Complications; 2016; 30(8):1467-1472. PubMed ID: 27522272
[TBL] [Abstract][Full Text] [Related]
19. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice.
Ka SM; Yeh YC; Huang XR; Chao TK; Hung YJ; Yu CP; Lin TJ; Wu CC; Lan HY; Chen A
Diabetologia; 2012 Feb; 55(2):509-19. PubMed ID: 22086159
[TBL] [Abstract][Full Text] [Related]
20. Tyro3 is a podocyte protective factor in glomerular disease.
Zhong F; Chen Z; Zhang L; Xie Y; Nair V; Ju W; Kretzler M; Nelson RG; Li Z; Chen H; Wang Y; Zhang A; Lee K; Liu Z; He JC
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
